NewAmsterdam Pharma Company N.V. (NAMS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 20.05 |
| Open | 19.99 |
| Bid | 20.01 x 100 |
| Ask | 20.14 x 100 |
| Day's range | 19.59 - 20.23 |
| 52-week range | 5.63 - 26.35 |
| Volume | |
| Avg. volume | 192,114 |
| Market cap | 1.808B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
NewAmsterdam Pharma First Quarter 2024 Earnings: US$1.06 loss per share (vs US$0.50 loss in 1Q 2023)
NewAmsterdam Pharma ( NASDAQ:NAMS ) First Quarter 2024 Results Key Financial Results Net loss: US$93.8m (loss widened...
- Simply Wall St.
NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations
NewAmsterdam Pharma ( NASDAQ:NAMS ) Full Year 2023 Results Key Financial Results Revenue: US$14.1m (down 87% from FY...
- GuruFocus.com
NewAmsterdam Pharma Co NV (NAMS) Faces Net Loss in 2023 Despite Clinical Progress
Company Advances Clinical Trials and Strengthens Financial Position
© 2024 Yahoo. All rights reserved.